REYON Pharmaceutical Co., Ltd.
KSE 102460.KS
REYON Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2023: 0.72%
-
REYON Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2022 was 1.53%, a 32.39% change year over year.
-
REYON Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2021 was 1.16%, a -4.29% change year over year.
-
REYON Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2020 was 1.21%, a -44.08% change year over year.
-
REYON Pharmaceutical Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2019 was 2.16%, a 388.69% change year over year.
| Date | Return on Assets (ROA) | Return on Equity (ROE) | Return on Capital Employed (ROCE) | Interest Coverage Ratio |
|---|
| CEO | Ms. Soon-Ock Jung |
| IPO Date | June 10, 2010 |
| Location | South Korea |
| Headquarters | 416 Yeongdong-daero |
| Employees | 466 |
| Sector | Health Care |
| Industries | |
REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.
Past 5 years
USD 8.46
USD 7.02
USD 89.82
StockViz Staff
January 15, 2025
Any question? Send us an email